Cargando…
A single proteolytic cleavage within the lower hinge of trastuzumab reduces immune effector function and in vivo efficacy
INTRODUCTION: Recent studies reported that human IgG antibodies are susceptible to specific proteolytic cleavage in their lower hinge region, and the hinge cleavage results in a loss of Fc-mediated effector functions. Trastuzumab is a humanized IgG(1 )therapeutic monoclonal antibody for the treatmen...
Autores principales: | Fan, Xuejun, Brezski, Randall J, Fa, Ming, Deng, Hui, Oberholtzer, Allison, Gonzalez, Anneliese, Dubinsky, William P, Strohl, William R, Jordan, Robert E, Zhang, Ningyan, An, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680949/ https://www.ncbi.nlm.nih.gov/pubmed/22873525 http://dx.doi.org/10.1186/bcr3240 |
Ejemplares similares
-
Proteolytic single hinge cleavage of pertuzumab impairs its Fc effector function and antitumor activity in vitro and in vivo
por: Hsiao, Hao-Ching, et al.
Publicado: (2018) -
The Origins, Specificity, and Potential Biological Relevance of Human Anti-IgG Hinge Autoantibodies
por: Brezski, Randall J., et al.
Publicado: (2011) -
The Proteolytic Cleavage of Therapeutic Monoclonal Antibody Hinge Region: More Than a Matter of Subclass
por: Deveuve, Quentin, et al.
Publicado: (2020) -
Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation
por: Shi, Yun, et al.
Publicado: (2014) -
An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions
por: Kinder, Michelle, et al.
Publicado: (2015)